Posted by Michael Wonder on 05 Aug 2020
Johnson & Johnson reaches deal with U.S. for 100 million doses of coronavirus vaccine at more than $1 billion
5 August 2020 - The doses will be provided to Americans at no cost if they’re used in a COVID-19 vaccination campaign, although health care professionals could charge for the cost of administering the vaccine, HHS said in a statement.
Johnson & Johnson announced Wednesday that it will develop and deliver 100 million doses of its coronavirus vaccine for the U.S. in a deal totalling more than $1 billion.
The company’s experimental vaccine is currently in early stage human trials and is expected to begin late-stage human trials in September, executives have previously said. The deal gives the U.S. the option to order an additional 200 million doses, according to the announcement.
“We are scaling up production in the U.S. and worldwide to deliver a SARS-CoV-2 vaccine for emergency use,” said Dr. Paul Stoffels, chief science officer at Johnson & Johnson, in a statement.
